{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:08:31Z","timestamp":1772798911320,"version":"3.50.1"},"reference-count":10,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1793,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1865-1682.2010.01169.x","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T04:35:22Z","timestamp":1286166922000},"page":"430-433","source":"Crossref","is-referenced-by-count":5,"title":["Development of a Foot-and-Mouth Disease Infection Model in Severe Combined Immunodeficient Mice for the Preliminary Evaluation of Antiviral Drugs"],"prefix":"10.1155","volume":"57","author":[{"given":"D. J.","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,10,4]]},"reference":[{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.vaccine.2005.07.043","article-title":"Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7\u2003days and partial protection in 4\u2003days: use in emergency outbreak response","volume":"23","author":"Golde","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2006.09.007","article-title":"2\u2032-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus","volume":"73","author":"Goris","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jviromet.2009.05.005","article-title":"Validation of two real-time RT-PCR methods for foot-and-mouth disease diagnosis: RNA-extraction, matrix effect, uncertainty of measurement and precision","volume":"160","author":"Goris","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2006.03.010","article-title":"Protection of Balb\/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides","volume":"72","author":"Kamstrup","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB7|cit7","unstructured":"NIAID, The National Institute of Allergy and Infectious Diseases 2010 Antimicrobial acquisition and coordinating facility AACF, animal models of human viral infections for evaluation of experimental therapeutics http:\/\/niaid-aacf.org\/protocols\/In%20Vivo%20-%20Pox%20HSV%20CMV.pdf"},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB8|cit8","unstructured":"OIE, World Organisation for Animal Health 2010 Handistatus II. EUROPE\/2001\/Foot and mouth disease, animal health status http:\/\/www.oie.int\/hs2\/sit_mald_cont.asp?c_mald=2&c_cont=4&annee=2001"},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.20506\/rst.24.3.1632","article-title":"Selection of foot and mouth disease vaccine strains - a review","volume":"24","author":"Paton","year":"2005","journal-title":"Rev. Sci. Tech. Off. Int. Epiz."},{"key":"10.1111\/j.1865-1682.2010.01169.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.virol.2004.11.005","article-title":"Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice","volume":"332","author":"Salguero","year":"2005","journal-title":"Virology"}],"container-title":["Transboundary and Emerging Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1865-1682.2010.01169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1865-1682.2010.01169.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T15:41:04Z","timestamp":1675957264000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1865-1682.2010.01169.x"}},"subtitle":["FMD in SCID Mice"],"short-title":[],"issued":{"date-parts":[[2010,10,4]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1865-1682.2010.01169.x","relation":{},"ISSN":["1865-1674"],"issn-type":[{"value":"1865-1674","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,4]]}}}